Drugs / DSXS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02932462 | Mar → Dec 2016 | psoriasis | Sun Pharmaceutical Industries, Inc. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DSXS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02932462 ↗ |
| Route | Topical | “DSXS 1535 topical product” NCT02932462 ↗ |